realMIND: Observational Study on Safety and Effectiveness of Tafasitamab in Combination With Lenalidomide in Patients With Relapsed or Refractory DLBCL

Part of paid clinical trials in Birmingham, Alabama.

Sponsor
Incyte Corporation
Study ID
NCT04981795
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Tafasitamab — DRUG
    Observational Study on safety and effectiveness of tafasitamab in combination with lenalidomide inPatients With Relapsed or Refractory DLBCL.

Study Details

The realMIND study is a multicenter, observational study intended to further characterize the safety and effectiveness data of US patients (with a focus on racial and ethnic minority patients) with relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL), treated with tafasitamab in combination with lenalidomide.

Key Dates

Start date
Sep 20, 2021
Status verified
Apr 2026
Primary completion
Jan 23, 2026
Completion
Jan 23, 2026

Study Design

Enrollment
102 participants (actual)

Arms

  • Arm: 1
    Group 1: Racial and ethnic minority patients (at least 50 patients)
  • Arm: 2
    Group 2: Non Hispanic White (NHM) patients (at least 50 patients)

Primary Outcome Measure

Treatment Patterns - Safety [ Time Frame: 2 Years ]

Locations (26)

FacilityCityStateZIPSite coordinators
Alabama OncologyBirminghamAlabama35211-
Clearview Cancer InstituteHuntsvilleAlabama35805-
University of California, Irvine Medical CenterOrangeCalifornia92868-
McFarland Clinic P.C.AmesIowa50010-
Mission Cancer and BloodDes MoinesIowa50309-
Tulane Cancer CenterNew OrleansLouisiana70112-
American Oncology Partners of Maryland PABethesdaMaryland20817-
University of Michigan Comprehensive Cancer Center Michigan MedicineAnn ArborMichigan48109-
Henry Ford Health SystemDetroitMichigan48202-
Morristown Medical CenterMorristownNew Jersey07960-6136-
Rutgers Cancer Institute of New JerseyNew BrunswickNew Jersey08903-2681-
Westchester Medical CenterHawthorneNew York10532-
Levine Cancer InstituteCharlotteNorth Carolina28204-
Duke UniversityDurhamNorth Carolina27705-
VA Medical Center - DurhamDurhamNorth Carolina27705-
Leo Jenkins Cancer Center/ECU School of MedicineGreenvilleNorth Carolina27858-
Mercy Medical CenterCantonOhio44708-
Ohio Health Marion Area PhysiciansMarionOhio43302-
Tri County Hematology & Oncology Associates, IncMassillonOhio44646-
Integris Cancer Institute of OklahomaOklahoma CityOklahoma73142-
Thomas Jefferson UniversityPhiladelphiaPennsylvania19107-
Lankenau Medical CenterWynnewoodPennsylvania19096-
University of Texas MD Anderson Cancer CenterHoustonTexas77030-
UW MedicineSeattleWashington98109-
Yakima Valley Memorial Hospital/North Star LodgeYakimaWashington98902-
Froedtert & Medical College ClinicsMilwaukeeWisconsin53226-

Find similar trials in Birmingham, AL

By research site
Alabama Oncology· Birmingham, ALClearview Cancer Institute· Huntsville, ALUniversity of California, Irvine Medical Center· Orange, CAMcFarland Clinic P.C.· Ames, IAMission Cancer and Blood· Des Moines, IATulane Cancer Center· New Orleans, LA

Related Studies